Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 731

1.
4.

Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice.

Pozdnyakova O, Guttormsen HK, Lalani FN, Carroll MC, Kasper DL.

J Immunol. 2003 Jan 1;170(1):84-90.

5.

Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.

Martin D, Rioux S, Gagnon E, Boyer M, Hamel J, Charland N, Brodeur BR.

Infect Immun. 2002 Sep;70(9):4897-901.

6.

Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Baker CJ, Edwards MS, Webb BJ, Kasper DL.

J Clin Invest. 1982 Feb;69(2):394-404.

7.

Antibody-independent protection in mice against type Ia group B streptococcus lethal infection.

Scaringi L, Tissi L, Cornacchione P, Rosati E, Campanelli C, von Hunolstein C, Orefici G, Rossi R, Marconi P.

FEMS Immunol Med Microbiol. 1994 Aug;9(2):151-62.

PMID:
7804166
8.

The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

Baker CJ, Webb BJ, Kasper DL, Edwards MS.

J Infect Dis. 1986 Jul;154(1):47-54.

PMID:
3519791
9.
10.

Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.

Aoyagi Y, Adderson EE, Min JG, Matsushita M, Fujita T, Takahashi S, Okuwaki Y, Bohnsack JF.

J Immunol. 2005 Jan 1;174(1):418-25.

11.
12.

Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.

Tüzün E, Scott BG, Goluszko E, Higgs S, Christadoss P.

J Immunol. 2003 Oct 1;171(7):3847-54.

13.

Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.

Molina H, Miwa T, Zhou L, Hilliard B, Mastellos D, Maldonado MA, Lambris JD, Song WC.

Blood. 2002 Dec 15;100(13):4544-9. Epub 2002 Aug 1.

14.

Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.

Cunnion KM, Benjamin DK Jr, Hester CG, Frank MM.

J Lab Clin Med. 2004 Jun;143(6):358-65.

PMID:
15192652
15.

Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice.

Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH.

Clin Exp Immunol. 1997 Dec;110(3):403-9.

16.

Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Marques MB, Kasper DL, Shroff A, Michon F, Jennings HJ, Wessels MR.

Infect Immun. 1994 May;62(5):1593-9.

17.

Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.

Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD Jr, Rosen FS, Carroll MC.

J Immunol. 1997 Jul 15;159(2):976-82.

PMID:
9218619
18.

Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes.

Yuste J, Ali S, Sriskandan S, Hyams C, Botto M, Brown JS.

J Immunol. 2006 May 15;176(10):6112-20.

19.

Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.

Verbrugh HA, Peterson PK, Nguyen BY, Sisson SP, Kim Y.

J Immunol. 1982 Oct;129(4):1681-7.

PMID:
7108223
Items per page

Supplemental Content

Write to the Help Desk